Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer

Despite advances in diagnostic imaging, surgical techniques, and systemic therapy, gastric cancer (GC) is the third leading cause of cancer-related death worldwide. Unfortunately, molecular heterogeneity and, consequently, acquired resistance in GC are the major causes of failure in the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Moonsik, Jeong, Ji Yun, Seo, An Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487043/
https://www.ncbi.nlm.nih.gov/pubmed/37685320
http://dx.doi.org/10.3390/diagnostics13172782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487043/
https://www.ncbi.nlm.nih.gov/pubmed/37685320
http://dx.doi.org/10.3390/diagnostics13172782

Ejemplares similares